Related Experiment Video
Updated: Jul 1, 2025

10:47
Standardized and Scalable Assay to Study Perfused 3D Angiogenic Sprouting of iPSC-derived Endothelial Cells In Vitro
Published on: November 6, 2019
30.5K
Precision Culture Scaling to Establish High-Throughput Vasculogenesis Models
Nicholas R Dennison1, Maximilian Fusenig1,2, Lisa Grönnert3
1Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, 01069, Dresden, Germany.
Advanced Healthcare Materials
|March 11, 2024
Summary
Researchers developed a precision culture scaling (PCS-X) method to create advanced 3D cell models for drug discovery. This automated approach optimizes hydrogel cultures for high-throughput screening, enabling personalized therapies.
Area of Science:
- Biotechnology
- Cell Biology
- Drug Discovery
Background:
- 3D cell cultures in hydrogels mimic physiological conditions but are difficult to scale for high-throughput screening.
- Complex multifactorial regulation hinders the adaptation of these models for automated workflows.
Purpose of the Study:
- To develop a novel precision culture scaling (PCS-X) methodology for optimizing hydrogel-based 3D cell models.
- To enable parallelized, high-throughput screening of vasculogenesis cultures for drug discovery and personalized medicine.
Main Methods:
- Combined statistical design of experiments and multiple linear regression with automated, parallelized experiments.
- Systematically varied cell density, growth factor supplementation, and media composition in hydrogel cultures.
- Utilized human umbilical vein endothelial cells and retinal microvascular endothelial cells in 384-well plates.
Main Results:
- Successfully customized hydrogel-based vasculogenesis cultures using PCS-X.
- Demonstrated dose- and compound-dependent responses to vasculogenesis inhibitors.
- Established parallelized tissue and disease models suitable for drug discovery applications.
Conclusions:
- PCS-X methodology effectively enables the creation of scalable, high-throughput 3D cell models.
- The developed models show promise for accelerating drug discovery and the development of individualized therapies.

